Caldararo Mario, Algazaq Jumanah, Schmidt Elizabeth, Joanow Alexa, Mariano Amanda, Predmore Jacqueline, Politikos Ioannis, Cho Christina, Stein Eytan M, Wen Xiaoyoun, Travis William D, Raible Kevin, Cintron Melvili, Babady N Esther, Papanicolaou Genovefa, Lee Yeon Joo
Infectious Diseases Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Infect Dis Clin Pract (Baltim Md). 2022 Mar;30(2). doi: 10.1097/ipc.0000000000001101.
Identification of pathogens with pulmonary presentation in patients with hematologic malignancies may be challenging due to diagnostic difficulty related to the underlying malignancy and limitations of conventional microbiologic methods. Herein, we present a case series of three patients with pulmonary consolidations due to necrotizing pneumonia, pneumonia, and disseminated infection, who were diagnosed by microbial cell-free DNA next-generation sequencing. We observed that this new sequencing modality was in agreement with gold-standard diagnostics, posing a potential solution to the problem of limited capability in diagnosing infections in hematological malignancy patients.
由于与潜在恶性肿瘤相关的诊断困难以及传统微生物学方法的局限性,识别血液系统恶性肿瘤患者肺部表现的病原体可能具有挑战性。在此,我们报告了一系列三例因坏死性肺炎、肺炎和播散性感染导致肺部实变的病例,这些病例通过微生物游离DNA下一代测序得以诊断。我们观察到这种新的测序方式与金标准诊断结果一致,为解决血液系统恶性肿瘤患者感染诊断能力有限的问题提供了潜在的解决方案。